SAN DIEGO, July 6, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal and state securities laws by STAAR Surgical Company (NASDAQ: STAA) and certain of its officers and board members. STAAR designs, develops, manufactures and sells implantable lenses for the eye and delivery systems to deliver the lenses into the eye.
Specifically, a court issued a tentative ruling denying a motion to dismiss for a class action suit filed against STAAR. The class action alleges that misleading statements were made relating to FDA regulatory violations at STAAR's Monrovia manufacturing facility. The FDA cited several regulatory violations at the facility and stated that, among other things, "the methods used in, or the facilities or controls used for" manufacture, packing, storage or installations of STAAR's implantable lenses are "not in conformity with the current good manufacturing practice requirements."
If you are a long term shareholder, continuously holding shares before February 2013, you may have standing to hold STAAR harmless from the damage the officers and directors caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance.
If you are a long term shareholder of STAAR and wish to discuss your rights, please contact Jim Baker ([email protected]) by email or by phone at 619-814-4471.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
[email protected]
Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO
SOURCE Johnson & Weaver, LLP
Share this article